Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

JAK inhibitors are effective and safe for treating severe alopecia areata.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Type II keratins are uniquely phosphorylated during stress and mitosis, affecting their structure and function.

Ritlecitinib is an effective new treatment for Alopecia Areata.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Baricitinib shows promise for treating alopecia areata with mild side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.